XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Net Sales $ 20,195 $ 20,068 $ 63,507 $ 61,453
Cost of Products Sold 9,855 10,404 30,500 32,147
Selling, General and Administrative Expense 5,880 5,416 17,006 15,334
Impairment of Intangible Assets for Grooming Segment, Indefinite-Lived (Excluding Goodwill) 0 0 1,341 0
Operating Income 4,460 4,248 14,660 13,972
Interest Expense (233) (222) (705) (516)
Interest Income 104 83 366 191
Other Non-operating Income/(Loss), Net 260 179 570 473
Earnings/(Loss) from Continuing Operations Before Income Taxes 4,592 4,288 14,891 14,120
Income Taxes on Continuing Operations 812 864 3,061 2,774
Net Earnings 3,781 3,424 11,830 11,346
Net Income (Loss) Attributable to Noncontrolling Interest 27 27 88 77
Net Income (Loss) Attributable to Parent $ 3,754 $ 3,397 $ 11,742 $ 11,269
Basic Net Earnings Per Common Share        
Basic Net Earnings/(Loss) Per Common Share [1] $ 1.56 $ 1.41 $ 4.89 $ 4.67
Diluted Net Earnings Per Common Share        
Diluted Net Earnings/(Loss) Per Common Share [1] $ 1.52 $ 1.37 $ 4.75 $ 4.53
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.